Status:
COMPLETED
Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Pain
Inflammation
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The primary objective of this study is to investigate the efficacy and safety of bromfenac ophthalmic solution for treatment of ocular inflammation and pain in subjects who undergo cataract extraction...
Eligibility Criteria
Inclusion
- Scheduled for unilateral cataract surgery with no other ophthalmic surgical procedures planned during cataract surgery
- Agree to return for all required visits
- Agree to avoid disallowed medications
Exclusion
- Known hypersensitivity to bromfenac and salicylates
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
522 Patients enrolled
Trial Details
Trial ID
NCT00333918
Start Date
June 1 2006
End Date
March 1 2007
Last Update
February 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Irvine, California, United States, 92618